Do analysts rate AVNS or CNXU?

Conexeu Sciences has a consensus target price of $20.00, suggesting a potential upside of 84.16%. Given Conexeu Sciences' stronger consensus rating and higher possible upside, analysts clearly believe Conexeu Sciences is more favorable than Avanos Medical. Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Avanos Medical 1 Sell rating(s) 1 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.50 Conexeu Sciences 0 Sell rating(s) 1 Hold rating(s) 1 Buy rating(s) 0 Strong Buy rating(s) 2.50

Which has stronger valuation & earnings, AVNS or CNXU?

Conexeu Sciences has lower revenue, but higher earnings than Avanos Medical. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Avanos Medical $701.20M 1.67 -$72.90M -$1.61 N/A Conexeu Sciences N/A N/A N/A N/A N/A

Does the media prefer AVNS or CNXU?

In the previous week, Conexeu Sciences had 13 more articles in the media than Avanos Medical. MarketBeat recorded 14 mentions for Conexeu Sciences and 1 mentions for Avanos Medical. Conexeu Sciences' average media sentiment score of 0.86 beat Avanos Medical's score of 0.00 indicating that Conexeu Sciences is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Avanos Medical 0 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral Conexeu Sciences 0 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 1 Negative mention(s) 0 Very Negative mention(s) Positive

Which has preferable valuation & earnings, CNXU or AORT?

Artivion has higher revenue and earnings than Conexeu Sciences. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Conexeu Sciences N/A N/A N/A N/A N/A Artivion $458.69M 2.53 $9.77M $0.24 99.63

Does the media prefer CNXU or AORT?

In the previous week, Conexeu Sciences had 10 more articles in the media than Artivion. MarketBeat recorded 14 mentions for Conexeu Sciences and 4 mentions for Artivion. Artivion's average media sentiment score of 0.87 beat Conexeu Sciences' score of 0.86 indicating that Artivion is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Conexeu Sciences 0 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 1 Negative mention(s) 0 Very Negative mention(s) Positive Artivion 1 Very Positive mention(s) 2 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive

Which has higher earnings and valuation, CNXU or TNDM?

Conexeu Sciences has higher earnings, but lower revenue than Tandem Diabetes Care. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Conexeu Sciences N/A N/A N/A N/A N/A Tandem Diabetes Care $1.03B 1.02 -$204.71M -$1.40 N/A

Does the media prefer CNXU or TNDM?

In the previous week, Conexeu Sciences had 12 more articles in the media than Tandem Diabetes Care. MarketBeat recorded 14 mentions for Conexeu Sciences and 2 mentions for Tandem Diabetes Care. Conexeu Sciences' average media sentiment score of 0.86 beat Tandem Diabetes Care's score of 0.83 indicating that Conexeu Sciences is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Conexeu Sciences 0 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 1 Negative mention(s) 0 Very Negative mention(s) Positive Tandem Diabetes Care 1 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive

Which has higher valuation & earnings, CNXU or CNMD?

CONMED has higher revenue and earnings than Conexeu Sciences. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Conexeu Sciences N/A N/A N/A N/A N/A CONMED $1.37B 0.74 $47.06M $1.77 19.09

Does the media refer more to CNXU or CNMD?

In the previous week, Conexeu Sciences had 10 more articles in the media than CONMED. MarketBeat recorded 14 mentions for Conexeu Sciences and 4 mentions for CONMED. Conexeu Sciences' average media sentiment score of 0.86 beat CONMED's score of 0.08 indicating that Conexeu Sciences is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Conexeu Sciences 0 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 1 Negative mention(s) 0 Very Negative mention(s) Positive CONMED 0 Very Positive mention(s) 1 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral

Which has stronger valuation & earnings, CNXU or DRTS?

Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Conexeu Sciences N/A N/A N/A N/A N/A Alpha Tau Medical N/A N/A -$42.63M -$0.67 N/A

Is CNXU or DRTS more profitable?

Conexeu Sciences' return on equity of 0.00% beat Alpha Tau Medical's return on equity. Company Net Margins Return on Equity Return on Assets Conexeu Sciences N/A N/A N/A Alpha Tau Medical N/A -73.23% -52.90%

Does the media prefer CNXU or DRTS?

In the previous week, Conexeu Sciences had 6 more articles in the media than Alpha Tau Medical. MarketBeat recorded 14 mentions for Conexeu Sciences and 8 mentions for Alpha Tau Medical. Conexeu Sciences' average media sentiment score of 0.86 beat Alpha Tau Medical's score of 0.14 indicating that Conexeu Sciences is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Conexeu Sciences 0 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 1 Negative mention(s) 0 Very Negative mention(s) Positive Alpha Tau Medical 4 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral

Conexeu Sciences (CNXU) Competitors

$10.86 0.00 (0.00%)

Closing price 07/2/2026 04:00 PM Eastern

Extended Trading

$10.86 0.00 (-0.05%)

As of 07/2/2026 05:57 PM Eastern

Compare

CNXU vs. AVNS, AORT, TNDM, CNMD, and DRTS

Should you buy Conexeu Sciences stock or one of its competitors? MarketBeat compares Conexeu Sciences with other companies and stocks that may be similar based on industry, sector, market capitalization, business model, investor interest, or shared news coverage. Companies and stocks commonly compared with Conexeu Sciences include Avanos Medical (AVNS), Artivion (AORT), Tandem Diabetes Care (TNDM), CONMED (CNMD), and Alpha Tau Medical (DRTS). These companies are all part of the "medical equipment" industry.

How does Conexeu Sciences compare to Avanos Medical?

Avanos Medical (NYSE:AVNS) and Conexeu Sciences (NASDAQ:CNXU) are both small-cap medical equipment companies, but which is the better investment? We will contrast the two companies based on the strength of their valuation, earnings, risk, profitability, analyst recommendations, institutional ownership, media sentiment and dividends.

Conexeu Sciences has lower revenue, but higher earnings than Avanos Medical.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Avanos Medical	$701.20M	1.67	-$72.90M	-$1.61	N/A
Conexeu Sciences	N/A	N/A	N/A	N/A	N/A

Conexeu Sciences has a consensus target price of $20.00, suggesting a potential upside of 84.16%. Given Conexeu Sciences' stronger consensus rating and higher possible upside, analysts clearly believe Conexeu Sciences is more favorable than Avanos Medical.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Avanos Medical	1 Sell rating(s)	1 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.50
Conexeu Sciences	0 Sell rating(s)	1 Hold rating(s)	1 Buy rating(s)	0 Strong Buy rating(s)	2.50

In the previous week, Conexeu Sciences had 13 more articles in the media than Avanos Medical. MarketBeat recorded 14 mentions for Conexeu Sciences and 1 mentions for Avanos Medical. Conexeu Sciences' average media sentiment score of 0.86 beat Avanos Medical's score of 0.00 indicating that Conexeu Sciences is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Avanos Medical	0 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral
Conexeu Sciences	0 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	1 Negative mention(s)	0 Very Negative mention(s)	Positive

95.2% of Avanos Medical shares are owned by institutional investors. 2.3% of Avanos Medical shares are owned by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock is poised for long-term growth.

Conexeu Sciences has a net margin of 0.00% compared to Avanos Medical's net margin of -10.39%. Avanos Medical's return on equity of 5.39% beat Conexeu Sciences' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Avanos Medical	-10.39%	5.39%	3.97%
Conexeu Sciences	N/A	N/A	N/A

Summary

Conexeu Sciences beats Avanos Medical on 6 of the 11 factors compared between the two stocks.

How does Conexeu Sciences compare to Artivion?

Conexeu Sciences (NASDAQ:CNXU) and Artivion (NYSE:AORT) are both small-cap medical equipment companies, but which is the better business? We will contrast the two businesses based on the strength of their media sentiment, institutional ownership, risk, analyst recommendations, dividends, valuation, earnings and profitability.

Conexeu Sciences presently has a consensus target price of $20.00, suggesting a potential upside of 84.16%. Artivion has a consensus target price of $44.17, suggesting a potential upside of 84.72%. Given Artivion's stronger consensus rating and higher possible upside, analysts clearly believe Artivion is more favorable than Conexeu Sciences.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Conexeu Sciences	0 Sell rating(s)	1 Hold rating(s)	1 Buy rating(s)	0 Strong Buy rating(s)	2.50
Artivion	1 Sell rating(s)	0 Hold rating(s)	7 Buy rating(s)	0 Strong Buy rating(s)	2.75

In the previous week, Conexeu Sciences had 10 more articles in the media than Artivion. MarketBeat recorded 14 mentions for Conexeu Sciences and 4 mentions for Artivion. Artivion's average media sentiment score of 0.87 beat Conexeu Sciences' score of 0.86 indicating that Artivion is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Conexeu Sciences	0 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	1 Negative mention(s)	0 Very Negative mention(s)	Positive
Artivion	1 Very Positive mention(s)	2 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

Artivion has a net margin of 2.55% compared to Conexeu Sciences' net margin of 0.00%. Artivion's return on equity of 7.15% beat Conexeu Sciences' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Conexeu Sciences	N/A	N/A	N/A
Artivion	2.55%	7.15%	3.63%

Artivion has higher revenue and earnings than Conexeu Sciences.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Conexeu Sciences	N/A	N/A	N/A	N/A	N/A
Artivion	$458.69M	2.53	$9.77M	$0.24	99.63

86.4% of Artivion shares are held by institutional investors. 6.3% of Artivion shares are held by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock will outperform the market over the long term.

Summary

Artivion beats Conexeu Sciences on 10 of the 11 factors compared between the two stocks.

How does Conexeu Sciences compare to Tandem Diabetes Care?

Conexeu Sciences (NASDAQ:CNXU) and Tandem Diabetes Care (NASDAQ:TNDM) are both small-cap medical equipment companies, but which is the better stock? We will compare the two companies based on the strength of their analyst recommendations, risk, profitability, valuation, dividends, institutional ownership, earnings and media sentiment.

In the previous week, Conexeu Sciences had 12 more articles in the media than Tandem Diabetes Care. MarketBeat recorded 14 mentions for Conexeu Sciences and 2 mentions for Tandem Diabetes Care. Conexeu Sciences' average media sentiment score of 0.86 beat Tandem Diabetes Care's score of 0.83 indicating that Conexeu Sciences is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Conexeu Sciences	0 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	1 Negative mention(s)	0 Very Negative mention(s)	Positive
Tandem Diabetes Care	1 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

Conexeu Sciences presently has a consensus price target of $20.00, indicating a potential upside of 84.16%. Tandem Diabetes Care has a consensus price target of $29.13, indicating a potential upside of 90.11%. Given Tandem Diabetes Care's higher possible upside, analysts plainly believe Tandem Diabetes Care is more favorable than Conexeu Sciences.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Conexeu Sciences	0 Sell rating(s)	1 Hold rating(s)	1 Buy rating(s)	0 Strong Buy rating(s)	2.50
Tandem Diabetes Care	1 Sell rating(s)	11 Hold rating(s)	9 Buy rating(s)	1 Strong Buy rating(s)	2.45

Conexeu Sciences has a net margin of 0.00% compared to Tandem Diabetes Care's net margin of -9.20%. Conexeu Sciences' return on equity of 0.00% beat Tandem Diabetes Care's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Conexeu Sciences	N/A	N/A	N/A
Tandem Diabetes Care	-9.20%	-53.88%	-7.88%

Conexeu Sciences has higher earnings, but lower revenue than Tandem Diabetes Care.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Conexeu Sciences	N/A	N/A	N/A	N/A	N/A
Tandem Diabetes Care	$1.03B	1.02	-$204.71M	-$1.40	N/A

Summary

Conexeu Sciences beats Tandem Diabetes Care on 6 of the 10 factors compared between the two stocks.

How does Conexeu Sciences compare to CONMED?

Conexeu Sciences (NASDAQ:CNXU) and CONMED (NYSE:CNMD) are both small-cap medical equipment companies, but which is the better stock? We will contrast the two businesses based on the strength of their analyst recommendations, valuation, risk, profitability, institutional ownership, media sentiment, earnings and dividends.

CONMED has higher revenue and earnings than Conexeu Sciences.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Conexeu Sciences	N/A	N/A	N/A	N/A	N/A
CONMED	$1.37B	0.74	$47.06M	$1.77	19.09

In the previous week, Conexeu Sciences had 10 more articles in the media than CONMED. MarketBeat recorded 14 mentions for Conexeu Sciences and 4 mentions for CONMED. Conexeu Sciences' average media sentiment score of 0.86 beat CONMED's score of 0.08 indicating that Conexeu Sciences is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Conexeu Sciences	0 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	1 Negative mention(s)	0 Very Negative mention(s)	Positive
CONMED	0 Very Positive mention(s)	1 Positive mention(s)	2 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral

CONMED has a net margin of 4.00% compared to Conexeu Sciences' net margin of 0.00%. CONMED's return on equity of 13.84% beat Conexeu Sciences' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Conexeu Sciences	N/A	N/A	N/A
CONMED	4.00%	13.84%	6.05%

Conexeu Sciences currently has a consensus price target of $20.00, suggesting a potential upside of 84.16%. CONMED has a consensus price target of $39.50, suggesting a potential upside of 16.88%. Given Conexeu Sciences' stronger consensus rating and higher possible upside, equities analysts clearly believe Conexeu Sciences is more favorable than CONMED.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Conexeu Sciences	0 Sell rating(s)	1 Hold rating(s)	1 Buy rating(s)	0 Strong Buy rating(s)	2.50
CONMED	2 Sell rating(s)	5 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.71

Summary

Conexeu Sciences beats CONMED on 5 of the 9 factors compared between the two stocks.

How does Conexeu Sciences compare to Alpha Tau Medical?

Conexeu Sciences (NASDAQ:CNXU) and Alpha Tau Medical (NASDAQ:DRTS) are both small-cap medical equipment companies, but which is the superior stock? We will contrast the two businesses based on the strength of their profitability, dividends, analyst recommendations, media sentiment, earnings, institutional ownership, risk and valuation.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Conexeu Sciences	N/A	N/A	N/A	N/A	N/A
Alpha Tau Medical	N/A	N/A	-$42.63M	-$0.67	N/A

2.7% of Alpha Tau Medical shares are held by institutional investors. 39.5% of Alpha Tau Medical shares are held by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock is poised for long-term growth.

Conexeu Sciences currently has a consensus target price of $20.00, suggesting a potential upside of 84.16%. Alpha Tau Medical has a consensus target price of $12.60, suggesting a potential downside of 4.76%. Given Conexeu Sciences' stronger consensus rating and higher probable upside, research analysts clearly believe Conexeu Sciences is more favorable than Alpha Tau Medical.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Conexeu Sciences	0 Sell rating(s)	1 Hold rating(s)	1 Buy rating(s)	0 Strong Buy rating(s)	2.50
Alpha Tau Medical	2 Sell rating(s)	1 Hold rating(s)	4 Buy rating(s)	0 Strong Buy rating(s)	2.29

In the previous week, Conexeu Sciences had 6 more articles in the media than Alpha Tau Medical. MarketBeat recorded 14 mentions for Conexeu Sciences and 8 mentions for Alpha Tau Medical. Conexeu Sciences' average media sentiment score of 0.86 beat Alpha Tau Medical's score of 0.14 indicating that Conexeu Sciences is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Conexeu Sciences	0 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	1 Negative mention(s)	0 Very Negative mention(s)	Positive
Alpha Tau Medical	4 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral

Conexeu Sciences' return on equity of 0.00% beat Alpha Tau Medical's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Conexeu Sciences	N/A	N/A	N/A
Alpha Tau Medical	N/A	-73.23%	-52.90%

Summary

Conexeu Sciences beats Alpha Tau Medical on 6 of the 9 factors compared between the two stocks.

Get Conexeu Sciences News Delivered to You Automatically

Subscribe Now

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding CNXU and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.

CNXU vs. The Competition

Export

Metric	Conexeu Sciences	Surgical, Medical, And Dental Instruments And Supplies Industry	Manufacturing Sector	NASDAQ Exchange
Market Cap	$290.59M	$3.23B	$4.50B	$12.40B
Dividend Yield	N/A	N/A	17.12%	6.63%
P/E Ratio	N/A	20.07	23.91	24.72
Price / Sales	N/A	356.14	156.08	98.03
Price / Cash	N/A	8.98	35.72	58.15
Price / Book	N/A	5.79	13.25	6.45
Net Income	N/A	$7.39M	$113.80M	$336.71M
7 Day Performance	-0.91%	0.65%	0.92%	1.37%
1 Month Performance	-35.55%	-1.04%	-1.42%	1.67%
1 Year Performance	N/A	-40.05%	10.46%	23.99%

Conexeu Sciences Competitors List

Export

Company	MarketRank	Share Price	Analysts' Price Target	1Y Price Performance	Market Cap	Revenue	P/E Ratio	Employee Count	Indicator(s)
CNXU Conexeu Sciences	4.7327 of 5 stars	$10.86 flat	$20.00 +84.2%	N/A	$290.59M	N/A	N/A	4	Analyst Revision
AVNS Avanos Medical	0.4329 of 5 stars	$24.92 +0.1%	N/A	+101.8%	$1.17B	$701.20M	N/A	2,287	News Coverage
AORT Artivion	4.5606 of 5 stars	$23.63 +4.3%	$44.17 +86.9%	-22.6%	$1.10B	$458.69M	98.44	1,800	High Trading Volume
TNDM Tandem Diabetes Care	3.2858 of 5 stars	$16.24 +3.0%	$29.13 +79.3%	-10.3%	$1.08B	$1.01B	N/A	2,500	Gap Up
CNMD CONMED	3.6546 of 5 stars	$35.82 +3.6%	$39.50 +10.3%	-37.7%	$1.04B	$1.37B	20.24	3,900

Related Companies and Tools

Related Companies

Top 10 Stock Comparisons

This page (NASDAQ:CNXU) was last updated on 7/3/2026 by MarketBeat.com Staff.

From Our Partners

Unlock superior investment research and tools.

Get MarketBeat All Access

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Conexeu Sciences (CNXU) Competitors

CNXU vs. AVNS, AORT, TNDM, CNMD, and DRTS

How does Conexeu Sciences compare to Avanos Medical?

Summary

How does Conexeu Sciences compare to Artivion?

Summary

How does Conexeu Sciences compare to Tandem Diabetes Care?

Summary

How does Conexeu Sciences compare to CONMED?

Summary

How does Conexeu Sciences compare to Alpha Tau Medical?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

CNXU vs. The Competition

Conexeu Sciences Competitors List

Related Companies and Tools

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

Conexeu Sciences (CNXU) Competitors

CNXU vs. AVNS, AORT, TNDM, CNMD, and DRTS

How does Conexeu Sciences compare to Avanos Medical?

Which has stronger valuation & earnings, AVNS or CNXU?

Do analysts rate AVNS or CNXU?

Does the media prefer AVNS or CNXU?

Do insiders and institutionals hold more shares of AVNS or CNXU?

Is AVNS or CNXU more profitable?

Summary

How does Conexeu Sciences compare to Artivion?

Do analysts prefer CNXU or AORT?

Does the media prefer CNXU or AORT?

Is CNXU or AORT more profitable?

Which has preferable valuation & earnings, CNXU or AORT?

Do institutionals and insiders believe in CNXU or AORT?

Summary

How does Conexeu Sciences compare to Tandem Diabetes Care?

Does the media prefer CNXU or TNDM?

Do analysts rate CNXU or TNDM?

Is CNXU or TNDM more profitable?

Which has higher earnings and valuation, CNXU or TNDM?

Summary

How does Conexeu Sciences compare to CONMED?

Which has higher valuation & earnings, CNXU or CNMD?

Does the media refer more to CNXU or CNMD?

Is CNXU or CNMD more profitable?

Do analysts rate CNXU or CNMD?

Summary

How does Conexeu Sciences compare to Alpha Tau Medical?

Which has stronger valuation & earnings, CNXU or DRTS?

Do institutionals and insiders hold more shares of CNXU or DRTS?

Do analysts recommend CNXU or DRTS?

Does the media prefer CNXU or DRTS?

Is CNXU or DRTS more profitable?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

CNXU vs. The Competition

Conexeu Sciences Competitors List

Related Companies and Tools

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools